menu

Elaine Can’t Miss Another Game: Managing Osteoarthritis Pain in Vulnerable Populations

Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free

Elaine Can’t Miss Another Game: Managing Osteoarthritis Pain in Vulnerable Populations

close
0.25 credits
15 minutes
Elaine Can’t Miss Another Game: Managing Osteoarthritis Pain in Vulnerable Populations
Restart
Resume
Read full article
Choose a format
Get your free creditsSkip straight to the post-test if you have already participated in this activity
Media formats available:
Details
Presenters
Comments
  • Overview

    With limited treatment options available, the management of osteoarthritis-related pain remains challenging. This issue is especially relevant for patients with various comorbidities or who experience healthcare inequality. Therefore, implementation of a “whole-patient” osteoarthritis pain management approach is essential to maximize outcomes. This is especially true in vulnerable populations, and provider decision-making must include patient-centric factors such as biopsychosocial considerations, use of assessment tools for individual pain and function, and individualized care in line with a patient’s goals, preferences, and values.

    Let us guide you through a step-by-step case-based learning simulation that will enable you to incorporate new management strategies into your osteoarthritis medical practice—strategies that will better engage patients in their own care and lead to improved treatment outcomes.

  • Disclosure of Conflicts of Interest

    In accordance with the ACCME Standards for Commercial Support, Global Learning Collaborative (GLC) requires that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any commercial interest. GLC resolves all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all its educational programs.

    Faculty:
    Alvin F. Wells, MD, PhD
    Director, Aurora Rheumatology and Immunotherapy Center
    Franklin, WI
    Speakers Bureau: AbbVie, Amgen, BMS, Lilly, Pfizer, Novartis, Sanofi, UCD 

    Reviewers/Content Planners/Authors:

    • Stephen Chavez has nothing to disclose.
    • Barry A. Fiedel, PhD has nothing to disclose.
    • Jessica Kimball has nothing to disclose.
    • Tricia O’Leary has nothing to disclose.
    • Colleen Resnick has nothing to disclose.
  • Simulation Goal

    The goal of the activity is to improve the quality of care for vulnerable patient populations with osteoarthritis by developing your knowledge of appropriate treatment options and strategies focused on patient-centered care (PCC) and shared decision-making (SDM). 

  • Target Audience

    This activity is designed to meet the educational needs of rheumatologists, primary care physicians, pain specialists, orthopedic surgeons, orthopedists, physiatrists, and specialty advance practitioners that manage patients with osteoarthritis and/or chronic pain associated with osteoarthritis.

  • Accreditation and Credit Designation Statements

    Global Learning Collaborative is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    Global Learning Collaborative designates this enduring material for a maximum of .25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • Provider

    Prova Education, designs and executes continuing education founded on evidence-based medicine, clinical need, gap analysis, learner feedback, and more. Our mission is to serve as an inventive and relevant resource for clinical content and educational interventions across a broad spectrum of specialties. 

    Prova Education's methodology demonstrates a commitment to continuing medical education and the innovative assessment of its effects. Our goal is clear—to develop and deliver the very best education in the most impactful manner and to verify its results with progressive outcomes research. 

  • Commercial Support

    This activity is supported by an independent educational grant(s) from Eli Lilly and Pfizer.

  • Disclaimer

    The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of GLC and Prova Education. This presentation is not intended to define an exclusive course of patient management; the participant should use his/her clinical judgment, knowledge, experience and diagnostic skills in applying or adopting for professional use any of the information provided herein. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patients’ conditions and possible contraindications or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. Links to other sites may be provided as additional sources of information. Once you elect to link to a site outside of Prova Education you are subject to the terms and conditions of use, including copyright and licensing restriction, of that site.

    Reproduction Prohibited

    Reproduction of this material is not permitted without written permission from the copyright owner.

  • System Requirements

    Our site requires a computer, tablet, or mobile device and a connection to the Internet. For best results, a high-speed Internet connection is recommended (DSL/Cable/Fibre). We also recommend using the latest version of your favorite browser to ensure compliance with W3C standards, such as Chrome, Safari, Firefox, or Microsoft Edge.

  • Publication Dates

    Release Date:

    Expiration Date:

Facebook Comments

Recommended
Details
Presenters
Comments
  • Overview

    With limited treatment options available, the management of osteoarthritis-related pain remains challenging. This issue is especially relevant for patients with various comorbidities or who experience healthcare inequality. Therefore, implementation of a “whole-patient” osteoarthritis pain management approach is essential to maximize outcomes. This is especially true in vulnerable populations, and provider decision-making must include patient-centric factors such as biopsychosocial considerations, use of assessment tools for individual pain and function, and individualized care in line with a patient’s goals, preferences, and values.

    Let us guide you through a step-by-step case-based learning simulation that will enable you to incorporate new management strategies into your osteoarthritis medical practice—strategies that will better engage patients in their own care and lead to improved treatment outcomes.

  • Disclosure of Conflicts of Interest

    In accordance with the ACCME Standards for Commercial Support, Global Learning Collaborative (GLC) requires that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any commercial interest. GLC resolves all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all its educational programs.

    Faculty:
    Alvin F. Wells, MD, PhD
    Director, Aurora Rheumatology and Immunotherapy Center
    Franklin, WI
    Speakers Bureau: AbbVie, Amgen, BMS, Lilly, Pfizer, Novartis, Sanofi, UCD 

    Reviewers/Content Planners/Authors:

    • Stephen Chavez has nothing to disclose.
    • Barry A. Fiedel, PhD has nothing to disclose.
    • Jessica Kimball has nothing to disclose.
    • Tricia O’Leary has nothing to disclose.
    • Colleen Resnick has nothing to disclose.
  • Simulation Goal

    The goal of the activity is to improve the quality of care for vulnerable patient populations with osteoarthritis by developing your knowledge of appropriate treatment options and strategies focused on patient-centered care (PCC) and shared decision-making (SDM). 

  • Target Audience

    This activity is designed to meet the educational needs of rheumatologists, primary care physicians, pain specialists, orthopedic surgeons, orthopedists, physiatrists, and specialty advance practitioners that manage patients with osteoarthritis and/or chronic pain associated with osteoarthritis.

  • Accreditation and Credit Designation Statements

    Global Learning Collaborative is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    Global Learning Collaborative designates this enduring material for a maximum of .25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • Provider

    Prova Education, designs and executes continuing education founded on evidence-based medicine, clinical need, gap analysis, learner feedback, and more. Our mission is to serve as an inventive and relevant resource for clinical content and educational interventions across a broad spectrum of specialties. 

    Prova Education's methodology demonstrates a commitment to continuing medical education and the innovative assessment of its effects. Our goal is clear—to develop and deliver the very best education in the most impactful manner and to verify its results with progressive outcomes research. 

  • Commercial Support

    This activity is supported by an independent educational grant(s) from Eli Lilly and Pfizer.

  • Disclaimer

    The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of GLC and Prova Education. This presentation is not intended to define an exclusive course of patient management; the participant should use his/her clinical judgment, knowledge, experience and diagnostic skills in applying or adopting for professional use any of the information provided herein. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patients’ conditions and possible contraindications or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. Links to other sites may be provided as additional sources of information. Once you elect to link to a site outside of Prova Education you are subject to the terms and conditions of use, including copyright and licensing restriction, of that site.

    Reproduction Prohibited

    Reproduction of this material is not permitted without written permission from the copyright owner.

  • System Requirements

    Our site requires a computer, tablet, or mobile device and a connection to the Internet. For best results, a high-speed Internet connection is recommended (DSL/Cable/Fibre). We also recommend using the latest version of your favorite browser to ensure compliance with W3C standards, such as Chrome, Safari, Firefox, or Microsoft Edge.

  • Publication Dates

    Release Date:

    Expiration Date:

Facebook Comments

Programs 4/18/21